$REGN IMPORTANT NEWS: REGN and INO will present amazing results tomorrow regarding their joint clinical trial to treat the deadliest cancer, GBM (Biden’s son and McCain died from this brain cancer), showing overall survival at 18 months and Tcell immune responses. REGN2810 in combination with Inovio’s DNA drugs (INO 5401 and INO 9012). From Inovio’s site: “INO-5401 glioblastoma (GBM) overall survival at 18 months (OS18) data selected for late-breaking presentation at the Society for Neuro-Oncology 2020 Annual Meeting on November 20, 2020”
  • 1
1 Like